n acetyl bpc 157 BPC-157 Injectable Peptide for Healing & Recovery BPC-157 - Phoenix Peptide Labs

In vascular biology, the peptide seems to modulate nitric oxide synthesis, driving angiogenesis by upregulating eNOS and subsequent NO production

Not in-house testing

Individual peptide pricing breakdown Let us get specific

RGN-352 was shown to be safe and well-tolerated with no serious drug-related adverse events reported (PMID: 20536472) Phase 2 AMI trial (incomplete): RegeneRx designed a Phase 2 proof-of-concept trial (NCT01311518) to evaluate RGN-352 in approximately 75 patients with acute ST-segment elevation myocardial infarction (heart attack)

5-Amino-1MQ research is primarily driven by the obesity pharmacology sector